Interactions of sulindac and its metabolites with phospholipid membranes: An explanation for the peroxidation protective effect of the bioactive metabolite

Non-steroidal anti-inflammatory drugs (NSAIDs) treat inflammatory processes by inhibition of cycloxygenase (COX). However, their action against lipid peroxidation can be an alternative pathway to COX inhibition. Since inflammation and lipid peroxidation are cell-surface phenomena, the effects of NSAIDs on membrane models were investigated. Peroxidation was induced by peroxyl radical (ROO•) derived from AAPH and assessed in aqueous or lipid media using fluorescence probes with distinct lipophilic properties: fluorescein; HDAF and DPH-PA. The antioxidant effect of Sulindac and its metabolites was tested and related with their membrane interactions. Drug–membrane interactions included the study of: drug location by fluorescence quenching; drug interaction with membrane surface by zeta-potential measurements; and membrane fluidity changes by steady-state anisotropy. Results revealed that the active NSAID (sulindac sulphide) penetrates into the lipid bilayer and protects the membrane against oxy-radicals. The inactive forms (sulindac and sulindac sulphone) present weaker interactions with the membrane and are better radical scavengers in aqueous media.

[1]  E. Fernandes,et al.  Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. , 2005, Life sciences.

[2]  Ilpo Vattulainen,et al.  Distribution, Orientation, and Dynamics of DPH Probes in DPPC Bilayer , 2004 .

[3]  S. Reis,et al.  Influence of some anti-inflammatory drugs in membrane fluidity studied by fluorescence anisotropy measurementsPresented at the 17th Conference of the European Colloid & Interface Science Society, Firenze, Italy, September 21?26, 2003 , 2004 .

[4]  S. Reis,et al.  Zeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomes. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[5]  M. Mora,et al.  Interaction of tocopherols and phenolic compounds with membrane lipid components: evaluation of their antioxidant activity in a liposomal model system. , 2003, Life sciences.

[6]  D. Latowski,et al.  Thermotropic phase behaviour of alpha-dipalmitoylphosphatidylcholine multibilayers is influenced to various extents by carotenoids containing different structural features--evidence from differential scanning calorimetry. , 2003, Biochimica et biophysica acta.

[7]  Dejian Huang,et al.  High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. , 2002, Journal of agricultural and food chemistry.

[8]  D. Praticò.  Alzheimer's disease and oxygen radicals: new insights. , 2002, Biochemical pharmacology.

[9]  A. Bennett,et al.  COX-2 inhibitors compared and contrasted , 2001, Expert opinion on pharmacotherapy.

[10]  R. Prior,et al.  Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. , 2001, Journal of agricultural and food chemistry.

[11]  A. Wierzbicki,et al.  Molecular modeling study of COX-2 inhibition by diarylheterocycles and sulindac sulfide , 2001 .

[12]  D. Trombetta,et al.  In vitro evaluation of the antioxidant activity and biomembrane interaction of the lazaroid U-74389G. , 2001, Life sciences.

[13]  D. Ahnen,et al.  Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. , 2001, Cancer research.

[14]  A. Bennett,et al.  Anti-inflammatory drugs, cyclooxygenases and other factors , 2001, Expert opinion on pharmacotherapy.

[15]  J. McCord,et al.  The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.

[16]  R. Floyd.  Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  M. Prieto,et al.  Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. , 1998, Biochemistry.

[18]  London,et al.  Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth , 1998, Biochemistry.

[19]  D. C. Mitchell,et al.  Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. , 1998, Biophysical journal.

[20]  G. Strasburg,et al.  Development and validation of fluorescence spectroscopic assays to evaluate antioxidant efficacy. Application to metal chelators , 1997 .

[21]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[22]  A. Saija,et al.  Flavonoids as antioxidant agents: importance of their interaction with biomembranes. , 1995, Free radical biology & medicine.

[23]  D. Trombetta,et al.  Flavonoid-biomembrane interactions: A calorimetric study on dipalmitoylphosphatidylcholine vesicles , 1995 .

[24]  L. Barclay,et al.  Membrane peroxidation: inhibiting effects of water-soluble antioxidants on phospholipids of different charge types. , 1994, Free radical biology & medicine.

[25]  H. Garda,et al.  Lipid chain order and dynamics at different bilayer depths in liposomes of several phosphatidylcholines studied by differential polarized phase fluorescence. , 1994, Chemistry and physics of lipids.

[26]  B. Lentz,et al.  Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. , 1993, Chemistry and physics of lipids.

[27]  D. Lasič,et al.  Liposomes: From Physics to Applications , 1993 .

[28]  A. Kaszniak,et al.  Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.

[29]  D. Stolz,et al.  The impenetrability of 5-(N-hexadecanoyl)aminofluoroscein through endothelial cell monolayers is dependent upon its solution properties, not the presence of tight junctions. , 1992, Biochemical and biophysical research communications.

[30]  M. Prieto,et al.  Location and interaction of N-(9-anthroyloxy)-stearic acid probes incorporated in phosphatidylcholine vesicles , 1991 .

[31]  E Gratton,et al.  Orientational distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles as determined by global analysis of frequency domain fluorimetry data. , 1991, Biochemistry.

[32]  E. Gratton,et al.  A photophysical model for diphenylhexatriene fluorescence decay in solvents and in phospholipid vesicles. , 1991, Biophysical journal.

[33]  B. Lentz,et al.  Membrane “fluidity” as detected by diphenylhexatriene probes , 1989 .

[34]  M. Masserini,et al.  Studies on peroxidation of arachidonic acid in different liposomes below and above phase transition temperature. , 1988, Chemistry and physics of lipids.

[35]  B. Halliwell,et al.  Oxidants, inflammation, and anti‐inflammatory drugs , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  E. Oldfield,et al.  Deuterium nuclear magnetic resonance spectroscopic study of the fluorescent probe diphenylhexatriene in model membrane systems. , 1986, Biochemistry.

[37]  Y. K. Levine,et al.  The static and dynamic behaviour of fluorescent probe molecules in lipid bilayers , 1986 .

[38]  R. Dale,et al.  Transverse location of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene in model lipid bilayer membrane systems by resonance excitation energy transfer. , 1985, Biochemistry.

[39]  S. Fan,et al.  Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study. , 1981, Journal of medicinal chemistry.

[40]  S. Hwang,et al.  Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes. , 1981, Journal of medicinal chemistry.

[41]  Y. Barenholz,et al.  Fluidity parameters of lipid regions determined by fluorescence polarization. , 1978, Biochimica et biophysica acta.

[42]  A. Visser,et al.  Fluorescence dynamics of diphenyl-1,3,5-hexatriene-labeled phospholipids in bilayer membranes. , 1994, Biophysical chemistry.

[43]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[44]  R. New,et al.  Liposomes : a practical approach , 1990 .

[45]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .